Regulatory submissions and compliance reporting remain among the most time-consuming and error-prone processes in the Swiss pharmaceutical industry. Manual dossier compilation, repeated data validation, and lengthy review cycles often delay market approvals by months while consuming significant resources from regulatory affairs teams. Leading Swiss life sciences companies are now deploying sovereign agentic regulatory systems that automatically compile submissions, generate compliant reports, and maintain continuous audit-ready documentation — all while keeping every piece of sensitive clinical and safety data securely on Swiss infrastructure.
- Regulatory submission preparation time reduced from months to weeks
- Error rates in dossiers decreased by 80–90% through intelligent validation
- Full EU AI Act and Swissmedic compliance with built-in explainability
- Sovereign deployment on Exoscale SKS guarantees complete data residency
- Regulatory affairs teams reclaim up to 70% of their time previously spent on manualcompilation
The Regulatory Bottleneck in Swiss Pharma
Preparing submissions for Swissmedic, EMA, or FDA requires pulling data from dozens of systems, cross-checking thousands of documents, and ensuring every section meets strict formatting and traceability requirements. Manual processes are slow, costly, and carry high risk of rejection due to inconsistencies or missing data.
The Sovereign Agentic Regulatory Submission Solution
A new generation of autonomous multi-agent systems is transforming regulatory affairs. These sovereign agentic platforms continuously monitor clinical data, safety reports, and manufacturing records to automatically compile complete, compliant submissions — all running inside dedicated Swiss tenants on Exoscale SKS.
How the Multi-Agent System Works
Built with LangGraph orchestration, the solution coordinates specialised agents:
• Data Aggregation & RAG Agent – securely pulls and enriches information from clinical, manufacturing, and pharmacovigilance systems
• Dossier Compilation Agent – assembles CTD modules and formats documents according to regulatory templates
• Compliance Validation Agent – performs real-time checks against EU AI Act, Swissmedic, and ICH guidelines
• Submission & Audit Agent – generates final eCTD packages and maintains full traceability for audits
The entire workflow is fully auditable and remains 100% within Swiss borders.
Proven Results from Swiss Life Sciences Companies
Early deployments have delivered impressive outcomes:
• Submission preparation time reduced from months to weeks
• First-time approval rates significantly improved
• Regulatory affairs operational costs reduced by 50–70%
• Full EU AI Act compliance achieved automatically with explainable AI
• Faster time-to-market for new therapies
Why Sovereignty Is Essential for Regulatory Compliance
Regulatory dossiers contain highly sensitive clinical trial data, patient information, and intellectual property. Foreign cloud solutions cannot meet the strict data residency and regulatory control requirements that Swiss pharma companies must satisfy. Sovereign agentic platforms deliver both speed and full Swiss compliance.
